NUDT15 and inflammatory bowel disease: Therefore, although the overall concentration of 6-TGN is unaltered, NUDT15 heterozygotes, with diminished NUDT15 protein stability, are supposed to have a higher ratio of 6-TGTP at the same dose than the wild genotype, and thus would be more likely to achieve the therapeutic threshold during IBD treatment.